Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INSULET CORP
Report date April 28, 2025 · Filed April 30, 2025
Section 16 reporting ended · disclosed 2025-04-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,247 |
Reported balance
After 2025-04-28 transaction · row 1
1 source rowRow 1 · 2025-04-28 · Tax withholding · Disposed 3,587 · Balance 61,247 F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.
RESMED INC
Report date June 30, 2022 · Filed August 18, 2022
Section 16 reporting ended · disclosed 2022-08-18. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2017 Filed Nov 22, 2017 15:48 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 7,019 | $43.63 | $306,238.97 |
DisclosureSEC source: 0001140361-17-043629 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:54 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,523 | $83.06 | $209,560.38 |
DisclosureSEC source: 0001140361-17-042708 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,390 F4 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:54 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,186 | $83.06 | $98,509.16 |
DisclosureSEC source: 0001140361-17-042708 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,913 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:54 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,483 | $83.06 | $206,237.98 |
DisclosureSEC source: 0001140361-17-042708 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,099 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014. F2 · balance_after: Includes 111 shares of ResMed stock purchased on October 31, 2017, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 10, 2017 Filed Oct 12, 2017 19:17 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 3,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-038516 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,471 F2 · shares: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on October 10, 2017, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| October 10, 2017 Filed Oct 12, 2017 19:17 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 3,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-038516 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,539 F1 · shares: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on October 10, 2017, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 15:19 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 7,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-032787 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,937 F2 · shares: Represents performance-based restricted stock units granted on February 16, 2017. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 15:19 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 14,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-032787 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,724 F1 · shares: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| July 14, 2017 Filed Jul 17, 2017 17:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,265 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001140361-17-027950 · doc1.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,019 Underlying: ResMed Common Stock · 5,265 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest ? per year. Read SEC document |
| July 14, 2017 Filed Jul 17, 2017 17:59 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,875 | $77.43 | $145,181.25 |
DisclosureSEC source: 0001140361-17-027950 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,218 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| July 14, 2017 Filed Jul 17, 2017 17:59 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,265 | $77.43 | $407,668.95 |
DisclosureSEC source: 0001140361-17-027950 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,093 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| July 14, 2017 Filed Jul 17, 2017 17:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,265 | $43.63 | $229,711.95 |
DisclosureSEC source: 0001140361-17-027950 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F2 · balance_after: Includes 298 shares of ResMed stock purchased on April 28, 2017, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 18:55 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,264 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001140361-17-016070 · doc1.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,284 Underlying: ResMed Common Stock · 5,264 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest ? per year. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 18:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,875 | $68.37 | $128,193.75 |
DisclosureSEC source: 0001140361-17-016070 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,795 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 18:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,264 | $68.37 | $359,899.68 |
DisclosureSEC source: 0001140361-17-016070 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,670 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 18:55 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,264 | $43.63 | $229,668.32 |
DisclosureSEC source: 0001140361-17-016070 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 22:22 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,264 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001140361-17-002310 · doc1.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,548 Underlying: ResMed Common Stock · 5,264 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest ? per year. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 22:22 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,820 | $64.44 | $117,280.80 |
DisclosureSEC source: 0001140361-17-002310 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,670 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 22:22 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,264 | $64.44 | $339,212.16 |
DisclosureSEC source: 0001140361-17-002310 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,490 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 22:22 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,264 | $43.63 | $229,668.32 |
DisclosureSEC source: 0001140361-17-002310 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 18:01 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 854 | $59.85 | $51,111.90 |
DisclosureSEC source: 0001140361-16-086732 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,490 F4 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 18:01 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,789 | $59.85 | $107,071.65 |
DisclosureSEC source: 0001140361-16-086732 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,344 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 18:01 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,503 | $59.85 | $89,954.55 |
DisclosureSEC source: 0001140361-16-086732 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,133 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/13/2013. F2 · balance_after: Includes 123 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 00:09 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,967 | $64.71 | $127,284.57 |
DisclosureSEC source: 0001140361-16-083103 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,513 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 00:13 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,264 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001140361-16-083021 · doc1.xml · derivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,812 Underlying: ResMed Common Stock · 5,264 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest ? per year. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 00:13 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,264 | $64.43 | $339,159.52 |
DisclosureSEC source: 0001140361-16-083021 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,480 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 00:13 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,264 | $43.63 | $229,668.32 |
DisclosureSEC source: 0001140361-16-083021 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.